Evaluation of serum cyfra21 in patients with pleural effusion

BACKGROUND: The aim of this study is to determine the level of serum cytokeratin19 fragment (cyfra21-1) in patients with benign or malignant pleural effusion and evaluation the sensitivity and specificity of this tumor marker. METHOD & MATERIAL: We prospectively evaluated 98 patients (39 maligna...

Descripción completa

Detalles Bibliográficos
Autores principales: Azimi, Q, Rezadoost, B, Jalali Nadoushan, M, Davati, A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Kowsar 2012
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3518977/
https://www.ncbi.nlm.nih.gov/pubmed/23285412

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3518977/
https://www.ncbi.nlm.nih.gov/pubmed/23285412

Ejemplares similares